Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose subcutaneous glucagon for hypoglycemia in type 1 diabetes
NCT01828125Phase 2Withdrawn
- Sponsor
- Montreal Clinical Research Institute
- Start
- Apr 2013
- Primary completion
- Dec 2013
- Countries
- 1
01
Overview
A Phase 2 trial of glucagon in type 1 diabetes mellitus (T1D), hypoglycemia, sponsored by Montreal Clinical Research Institute. Planned start Apr 2013; status: withdrawn.
02
Drugs
glucagon
03
Conditions
type 1 diabetes mellitus (T1D)hypoglycemia
Beyond the preview
Go deeper on NCT01828125.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01828125.